Search clinical trials for: Placebo

Total 53380 results

Helixmith Co., Ltd.

Active, not recruiting

Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy (REGAiN-1A)

Diabetic Neuropathy, Painful

United States
Amgen

Completed

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes | Thrombocytopenia | MDS
XWPharma

Completed

Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults

Healthy Volunteers

Australia
University College Dublin
Kerry Group

Completed

Probiotic-Muscle Study

Muscle Weakness | Old Age; Debility | Protein Deposition | Protein Deregulation

Ireland
San Francisco Veterans Affairs Medical Center

Suspended

Semaglutide to Reduce Atrial Fibrillation Burden

Obesity | Overweight | Atrial Fibrillation

United States
Akeso

Terminated

A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma

Asthma

China
Angitia Biopharmaceuticals

Completed

A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease

Degenerative Disc Disease

China
Novartis Pharmaceuticals

Completed

A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers (MAS-FIH)

Healthy Volunteers

United States, United Kingdom
Lallemand Health Solutions

Completed

Impact of Probiotic Supplementation on Exercise Endurance Among Non-elite Athletes

Exercise Endurance

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy Subjects

Type 2 Diabetes

China
Hepagene (Shanghai) Co., Ltd.

Active, not recruiting

Phase 2a Study of HPG1860 in Subjects With NASH (RISE)

NASH - Nonalcoholic Steatohepatitis

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants

Healthy Volunteers

United States
Gelesis, Inc.

Completed

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Obesity | Overweight

United States, Canada, Czechia, Denmark, Italy, Spain
Bayer

Terminated

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Moderate Chronic Kidney Disease

Denmark
Bayer

Completed

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough (PAGANINI)

Refractory and/or Unexplained Chronic Cough

Belgium, Taiwan, Australia, Netherlands, Spain, Japan, United States, Germany, Turkey, United Kingdom, Argentina, Italy, Slovakia, Hungary, France, Canada, Czechia, Poland, Russian Federation
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

Osteoarthritis | Knee

Japan
Eli Lilly and Company

Completed

A Study of LY3561774 in Participants With Dyslipidemia

Dyslipidemias

United States
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease (MODIFY)

Fabry Disease

United States, Spain, Belgium, Australia, Austria, Canada, Germany, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, United Kingdom
Boehringer Ingelheim

Completed

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Palmoplantar Pustulosis (PPP)

United Kingdom, Korea, Republic of, United States, Canada, Belgium, Australia, Taiwan, Japan, France, Germany, Russian Federation, Hungary, Netherlands, Czechia, Poland
Novo Nordisk A/S

Completed

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER 6)

Diabetes Mellitus, Type 2 | Diabetes

United States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
Cortexyme Inc.

Completed

A Single and Multiple Ascending Dose Study of COR588

Healthy Volunteers

Australia
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne

Acne Vulgaris

United States, Germany, Netherlands
Charite University, Berlin, Germany

Completed

Randomized Study on Salt Intake and Energy Metabolism (TS4)

Healthy

Germany
Dizal Pharmaceuticals

Completed

A Study of DZD2269 in Healthy Adult Participants

Healthy Volunteers

United States
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Chronic Rhinosinusitis (Diagnosis) | Nasal Polyps

China
3D Medicines

Completed

Phase 1 Study of 3D229 in Healthy Subjects

Healthy Subject

China
Astellas Pharma Global Development, Inc.

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

Healthy Volunteers

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

Dyspepsia

Russian Federation
Dizal Pharmaceuticals

Completed

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Healthy Volunteers

United States
Odense University Hospital

Completed

DNA Fragmentation - Effect on Pregnancy Rate

Infertility, Male
Alkahest, Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson Disease

United States, France, Australia
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of RBD1016

Healthy Volunteers

Australia
University of Zurich

Completed

Preserve-Transplant Study

Renal Insufficiency | Kidney Transplantation | Acidosis

Switzerland
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK3280 in Chinese Healthy Volunteers

Healthy

China
Tigenix S.A.U.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain; Academisch... and other collaborators

Completed

Cx611-0204 SEPCELL Study (SEPCELL)

Bacterial Pneumonia

Spain, Belgium, France, Italy, Lithuania, Norway
HighTide Biopharma Pty Ltd

Completed

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

Primary Sclerosing Cholangitis (PSC)

United States, Canada
Tanta University

Completed

The Possible Effects of Roflumilast on Obesity Related Disorders

Obesity | PreDiabetes

Egypt
Xi'an Biocare Pharma Ltd.

Completed

A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

Healthy

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Insomnia Disorder

United States, Korea, Republic of, Germany, Belgium, Bulgaria, Canada, Czechia, Finland, France, Hungary, Sweden
Heptares Therapeutics Limited

Terminated

A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562

Healthy

United Kingdom
EpiEndo Pharmaceuticals

Completed

Single and Multiple Ascending Dose Study With EP395

Adult ALL

United Kingdom
Otolith Labs

Active, not recruiting

Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus

Tinnitus

United States
BerGenBio ASA

Completed

A First-time-in-human Study of BGB149

Healthy Volunteers

United Kingdom
Sunshine Lake Pharma Co., Ltd.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects

Idiopathic Pulmonary Fibrosis

China
Cellenkos, Inc.

Completed

REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia (RESOLVE)

ARDS | COVID19

United States
Brigham and Women's Hospital
Apnimed

Completed

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing

Sleep Disordered Breathing

United States, Australia
Hospital Universitari Vall d'Hebron Research Institute

Completed

Treatment of Functional Abdominal Distension

Dyspepsia | Irritable Bowel Syndrome

Spain
Eli Lilly and Company

Completed

A Study to Evaluate LY3154207 on the Brain of Healthy Participants

Healthy

United States
Azienda Ospedaliero-Universitaria Consorziale Policlinico...
University of Bari Aldo Moro

Completed

NATURE 3.1_New Approach for the Reduction of REnal Uremic Toxins (NATURE31)

Healthy | Chronic Kidney Diseases

Italy
Galapagos NV

Completed

A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects

Healthy

Belgium

Search clinical trials for: Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations